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Preliminary  studies  indicate  that  properdin  may play a  significant  role in 
maintaining  the resistance of the body against bacteria (1, 2), viruses (3), and 
postradiation  bacteriemia  (4).  Furthermore,  Pillemer  and  coworkers  have 
demonstrated (5, 6) that properdin is involved in the reaction between zymosan 
and the complement component,  C'3, a system which is amenable to study in 
~tro. These workers have proposed an assay for properdin in which dilutions of 
test  serum,  zymosan,  and  RP  t  are  incubated  together,  after  which  residual 
C'3 is determined. Since little information was available as to the nature of the 
reaction,  it was explored,  utilizing  a  new and  more precise technique  for de- 
termining residual C'3. 
Materials and Methods 
Human Complement (Hu C').t---The pooled serum from healthy human  donors was dis- 
tributed  in small vials and kept frozen at  --20°C. 
Sendtlzed  Sheep Ce//*  (EA).a--Sheep  cells' preserved with trisodinm  ethylenediamine- 
tetraacetic  acid,  s  (NaaE.D.T.A.) 6 and  penicillin  (7),  were standardized  and  sensitized by 
the method of (8). 
Buffer.--Veronal buffer (9)  containing 0.00015 ~r Ca  ++ and 0.0005 m Mg  ++ was  used  for 
all dilutions and washings. 
Zyraosan.--Preparation LF_~I  4 was used  throughout  this work and was activated before 
use as described in reference 10. 
F.a4kuC'a.--The EAhuC'x complex (11), the combination of F_.A with what are believed 
* A pre|;mln,ry report of this work was given at the 3rd International  Congress of Bio- 
chemistry,  Brussels,  August 3,  1955. 
t  This work was supported by the Prentiss Foundation. 
t RP  is serum  devoid  of properdin  but  containing  all  the  components  of complement 
(C'I,  C'2,  C'3,  and  C'4). 
s Hu C', human complement. 
t EA, sensitized sheep cells. 
4 Kindly supplied by Dr. L. Pillemer. 
s Kindly supplied as the 3x recrystallized disodinm salt by Alrose Chemical Co., Provi- 
dence. 
s E.D.T.A.,  ethylenediaminetetraacetic acid. 
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to be C'I, C'2, and C'4, was prepared by addition of 20.0 ml. of a sublytic dilution of hu C', 
usually hu C'/100, to a mixture of 40.0 ml. of EA and 40.0 ml. of buffer at 37°C. After 2 to 
3 minutes, 2 volumes of chilled saline were added, the mixture was rapidly cooled to 4-6°C. 
and  aliquots  of  this  standard  suspension  of EAhuC'A were  added  to  chilled  tubes.  After 
centrifugation in  the  cold,  the  supernatants  were poured  off,  the  tubes  were wiped  with 
filter paper, and the EAhuC'x button broken up by tapping the tubes with the fingers.  Once 
formed, EAhuC'A deteriorates rapidly unless precautions are taken to maintain the tempera- 
ture at 4-6°C. 
Kinetic Technique.--All reactions were carried out in baths controlled to +0.1°C., using 
a wrist action shaker for mixing. 
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FIG. 1. The effect of varying quantities of serum 0.0075  ~  in NasE.D.T.A. on a constant 
quantity of EAhuC'A. 
RESULTS 
Effect of Varying C'3 on Lysis of EAhuC'a.--It  has already been shown (11) 
that  hu  C'3,  in common with guinea pig CP3  (12)  is  active  in  the  absence  of 
divalent  cations.  Thus,  human  serum treated  with  NaaE.D.T.A.  can provide 
C'3 whereas it cannot  provide C'A  since  the formation  of EAhuC'x  requires 
Ca  ++  (11). 
EAhuC'A were prepared  as  described under  Materials  and  Methods.  In  this particular 
experiment,  5.0  ml.  aliquots  of the  diluted  mixture were added  to  the chilled tubes.  The 
packed EAhuC'A obtained were resuspended in the cold with 3.5 ml. of varying dilutions of 
hu C', 0.0075 M in Na3E.D.T.A. The mixtures were incubated for 1 hour at 32°C.,  the  opti- 
mal temperature for lysis by hu  C' (13),  and then centrifuged. The optical densities of the 
supernatants  are plotted  (Fig.  1)  against  the relative concentration of C'3 added. IV[YRON  A.  LEON  287 
A  direct relationship between added C'3 and lysis exists over a  considerable 
range.  Thus, by adding suitable dilutions  of standard and unknown serum to 
EAhuC~A and comparing the slopes of the linear portions of the plots of lysis 
vs. concentration, it is possible to have a  precise measure of CP3 content. If an 
accurate measure of variations in the CP3 content of a  single pool, subjected to 
varying conditions, is all that is necessary, the standard serum may be omitted, 
provided dilutions are used that fall on the linear portion of the curve. 
Kinetics  of the Reaction  between ?roperdin,  Zymosan,  and  C'3  at  Various 
Temperatures.--Having  established  a method for quantitative  measurement of 
C'3,  the  interaction  between  properdin,  zymosan,  and  C'3  was  studied  at 
37°C.,  32°C.,  27°C.,  and 22°C.  Two consecutive reactions  are involved here: 
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FIG. 2. The effect of temperature  on the kinetics of the over-aU reaction between zymosan, 
properdin and C'3. 
first, the combination of properdin with zymosan to form the PZ complex; and 
second, the reaction of PZ with C'3. 
10.0 ml. of human serum equilibrated  at the temperature  of the experiment were added 
at 0 time to a  tube containing  10 rag. of zymosan. 0.S ml. samples were withdrawn  at in- 
tervals,  mixed with 1.0 ml. of cold buffer, and centrifuged immediately.  1.0 ml. portions  of 
the supernatants  were diluted with 6.0 ml. of cold buffer and 0.3 ml. of 0.15 ~ Na,E.D.T.A. 
3.5 ml. aliquots  of the cold, diluted  supernatants  were added  to tubes  containing  packed 
EAhuC'A  (from  S.0  ml.  of standard  EAhuC'A suspension) which were  mixed, stoppered, 
and incubated  at 32°C. for 1 hour.  The optical  densities obtained  are plotted against  the 
time  of sampling on semilog paper  (Fig. 2). 
The data obtained fit first order kinetics quite well. To obtain the energy of 
activation  of the  over-all reaction,  the  logarithms  of the  rate  constants  (ob- 
tained from the data of Fig. 2) were plotted against the reciprocals of the ab- 288  PROPERDIN-COMPLEMENT SYSTEM 
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ture at which the reaction was run. 
TABLE I 
Protocol for Experimen~  3.  Varying Dilutions  of Serum Set up wlth a Constanl  Concentration 
of Zymosan 
Flask  Serum dilution 
A  1/16 
B  1/8 
c  1/4 
D  1/2 
E  Undiluted 
~erum 
ml. 
4O 
20 
10 
5 
5 
Zymosan 
mg. 
4O 
20 
10 
5 
5 
TI 
mln, 
0.0 
0.5 
0.9 
1.3 
1.6 
Sample 
volume 
ml. 
4.0 
2.0 
1.0 
0.5 
0.5 
Buffe~ 
ral. 
2.0 
4.0 
5.0 
5.5 
11.5 
ml. 
0.3 
0.3 
0.3 
0.3 
0.6 
solute temperatures (Fig. 3). A value of 20,500 calories per mole was found. 
This value represents the activation energy of the rate-limiting reaction. At 
present it is not known whether the formation of PZ or the reaction of PZ with 
C'3 is rate-limiting. MYRON  A. LEON  289 
Effect of Varying Serum Conventration.--Varying dilutions of serum were in- 
cubated at 32°C. with zymosan at a final concentration of 1 mg./ml, as shown 
in Table I. 
The volumes sampled from each series were chosen so  that when added  to  buffer and 
Na~E.D.T.A. the final dilution of serum, in all cases, would be 1 up to 25.2. The NasE.D.T.A. 
was used to bind Mg  ++ and thus block further reaction of zymosan, and of PZ (5). 3.5 ml. 
0 
X 
>. 
I- 
Z 
E3 
,...I 
<t 
O. 
o 
8 
7 
6  " 
El 
El 
b  ,  I  I 
3  6  9  ,5  ,'8  2,  2'. 
MINUTES 
Fro. 4. The effect of serum dilution on the reaction of zymosan with properdin and Ct3. 
aliquots of the diluted samples were added to the packed  cells obtained from  10.0 ml.  of 
standard EAhuC~ suspension and incubated at 32°C. for 1 hour. 
Inspection of the results,  (Fig.  4),  shows  that  the concentration  of serum 
has a  profound effect on the rate as well as on the order of the reaction.  In 
dilute serum (1/8,  1/16)  the rate of inactivation of C'3 does not become ap- 
preciable  for some  time  and  then  rapidly  increases.  This  suggests  that  the 
formation of  the  PZ  complex may be  slow  at  these  serum  dilutions.  Once 
formed, the PZ rapidly inactivates the C'3 present. The decrease in reaction rate 
found with sera more concentrated than 1/4 does not appear to affect the first 290  PROPERDIN-COMPLEMENT  SYSTEM 
order kinetics of the reaction. The cause of this phenomenon is currently under 
investigation. 
Effect of Varying  Zymosan Concentration.-- 
Varying concentrations  of zymosan were incubated with 5.0 ml. of a 1/2 dilution of serum 
at 32°C. 0.5 ml. samples were pipetted into a mixture  of 6.0 ml. of cold buffer and 0.3 ml. 
of 0.15 ~ Na3E.D.T.A. Analyses for relative C'3 content  were carried out as in the previous 
expt. 
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FIo. 5. The effect of zymosan concentration  on the reaction between zymosan, properdin 
and C'3. The quantifies  of zymosan added were O, 10 rag., A, 7.5 rag., X, 5 nag., V, 3.75 
nag., [3, 2.5  rag.,  [],  1.25  rag. 
From Fig. 5 it appears that the reaction follows first order kinetics provided 
an excess of zymosan is present.  At low zymosan concentrations the reaction 
tapers off, possibly owing to saturation of PZ with C'3, or to inactivation of the 
small amount of PZ present in the course of reacting with excess C'3. 
Kinetics  of the Reaction between Dextran,  Properdin,  and C'3.-- 
1.0 ml. samples of dextran  No. B1355 S¥,  5  mg./ml., were added  at  zero  time to  6.0 
ml. of human  serum at both 32 and 37°C. 0.5 ml. samples were mixed with 1.0 ml. of cold 
Obtained through  the courtesy of Dr. E. A. Kabat. MYRON  A.  LEON  291 
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FIG. 6.  Kinetics  of  the over-aU  reaction between dextran B1355  84,  properdha  and C'3 
at 37"C., G, and 32°C., ~X. 
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FIG. 7. Effect of varying quantities of PZ on a constant amount of C'a. 292  PROPERDIN-COMPLEMENT  SYSTEM 
buffer and 0.075 ml. of 0.15 -  NaaE.D.T.A. 1.0 ml. of these mixtures were added to tubes 
containing 6.0 ml. of buffer and 0.35 ml. of 0.15 ~x NatE.D.T.A. The analyses for C'3 were 
carried out as in the previous experiment. 
From the data, graphed in Fig. 6, an activation energy of 48,000 cal./mole 
was calculated.  The reaction is far more temperature-sensitive  than that in- 
volving zymosan and may well  involve different spatial configurations of the 
glucose residues. 
Stoichiometry  of the Reaction  Between  PZ and C'3.-- 
20 rag. of zymosan was shaken with 10 ml. of hu C' for 1 hour at 16.3°C., to form the 
properdin-zymosan complex (PZ) (5). PZ was centrifuged off in the cold, washed once with 
5 ml. of cold buffer and resuspended in I0 ml. of cold buffer to give a final concentration of 
2 mg./ml. A series of dilutions of PZ in cold buffer was prepared using calibrated pipettes. 
1.0 ml. portions of these dilutions were added to 1.0 ml. of RP that had been absorbed with 
zymosan at both 17°C. and 37"°C. (6). The mixtures were incubated at 37°C. for  1 hour. 
0.5 ml.  of the mixtures were then added to chilled tubes containing 3.0 hal. of cold buffer 
and 0.2 ml. of 0.15 ~ Na3E.D.T.A. 3.5 ml. of these dilutions were mixed with the packed 
cells from 10.0 ml. of EAhuC% and incubated for 1 hour at 32°C. 
The optical densities obtained are plotted against the quantity of PZ added 
in Fig. 7. A direct proportionality between PZ and optical density or C'3 was 
found. 
DISCUSSION 
The properdin  titration  proposed by Pillemer  and  coworkers  (5),  permits 
complications introduced  by the  unknown serum  at  both  stages  of the  re- 
action; the formation of PZ and the reaction of the PZ with C'3. That such 
complications do occur is evident from the data (Fig. 4) showing that undiluted 
serum can inhibit the reaction. It is possible,  however, to eliminate any inter- 
ference with the second stage of the reaction, by the unknown, if the procedure 
of the last experiment is used. The unknown is incubated with RP and zymosan 
at  15°C.  for 75 minutes.  The PZ complex is centrifuged in the cold, washed 
once with cold buffer, and resuspended in a  known volume of cold buffer. A 
measured amount of PZ suspension is  added  to RP and incubated at 37°C. 
for 1 hour. The residual C'3 is titrated with EAhuC'A. Since the optical density 
obtained is directly proportional to the quantity of PZ added,  the value ob- 
tained with the unknown is  simply fitted on the line found with a  standard 
serum pool as in Fig. 7. This method is currently being utilized in a study of the 
kinetics of the properdin zymosan reaction. 
Considerable  interest  has  been  aroused  by the  possibility  that  properdin 
levels may be of clinical importance. There is a question, however, as to whether 
the total properdin content of sera is as important as what may be termed the 
available  properdin.  Since unknown cofactors are  required  for properdin  to 
react in vitro, some or all of these factors may be necessary for the in vivo re- MYRON  A. LEON  293 
action of properdin. If this is true, there may be sera in which the total pro- 
perdin content is normal, but the amount of properdin available for reaction is 
limited, owing to a deficiency of some cofactor. This situation is not detectable 
by PiUemer's assay technique, since the RP added masks the absence of co- 
factors  in  the  unknown  serum.  Any  investigation  attempting to  correlate 
properdin  levels with clinical findings should,  therefore, measure both  total 
properdin and available properdin.  The  total properdin content of a  serum 
is measured by forming PZ with RP added to ensure that an optimal concentra- 
tion of cofactors is present. The available properdin of a serum is measured by 
forming the PZ complex without any added RP. The quantity of PZ formed 
will, therefore, depend on the concentration of cofactors present in the serum. 
SUMMARY 
Quantitative methods have been developed for the estimation of Ct3  and 
properdin. With these methods, the kinetics of the over-aU  reaction between 
properdin,  zymosan, and  C'3  were  investigated. The  reaction followed first 
order kinetics, provided zymosan was in excess,  and the  serum not diluted 
beyond 1/4.  The reaction rate was proportional to the temperature, and an 
activation energy of 20,500  calories/mole was found. 
The distinction between total properdin and available serum properdin is 
discussed. 
BIBLIOGRAPHY 
1.  Rowley, D., Lanc~A, 1955, 1, 232. 
2.  Wardlaw, A. C., Blum, L., and Pillerner, L., Fed. Proc., 1955, 14, 480. 
3.  Wedgewood, R. J., Ginsberg, H. S., Seibert, R. H., and PiUemer, L., Am. J. D/s. 
Child., 1955, 90, 508. 
4.  Ross, O. A., Moritz, A. R., Wallace, C. J., Wurz, L., Todd, E. W., and Pillemer, 
L., Fed. Proc., 1955, 14, 480. 
5.  Pillemer, L., Blum, L., Lepow, I. H., Ross, O. A., Todd, E. W., and Wardlaw, 
A. C., Science, 1954, 19.0, 279. 
6.  Pillemer, L., Schoenberg, M.  C., Blum,  L., and Wurz,  L., Sci.ence, 1955, 122, 
545. 
7.  Leon, M. A., Plescia, O. J., and Heidelberger, M., J. Immunol.,  1955, 74, 313. 
8.  Osler, A. G., Strauss, J. H., and Mayer, M. M., Am. J. Syph.,  1952, 86, 140. 
9.  Mayer, M. M., Osler, A. G., Bier, O. G., and Heidelberger, M., J. Exp. Med., 
1946, 84, 535. 
10.  PiIlemer, L., and Ecker, E. E., J. Biol. Chem., 1941, 187, 139. 
11.  Leon, M. A., J. Immunol., in press. 
12.  Levine, L., Mayer, M. M., and Rapp, H. J., J. Immunol.,  1954, 78, 435. 
13.  Leon, M. A., Proc. Sac. Exp. Biol. and Med., 1955, 89, 560. 